This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jinzhou Jiutai Pharmaceutical Co., Ltd., China, Shenyang Pharmaceutical University. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Maosheng Cheng: Innovator in Pharmaceutical Compounds
Introduction
Maosheng Cheng is a notable inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Maosheng Cheng holds 1 patent related to pharmaceutical compounds. His invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R is H, chlorine, or bromine. R is electron attractive groups selected from the group consisting of CF, CN, fluorine, CHSO, CFSO, and NO. R can also be linear or branched alkyl having 1 to 10 carbon atoms, linear or branched alkoxyalkyl having 2 to 10 carbon atoms, aliphatic alcohol having 1 to 10 carbon atoms, or cycloalkyl having 3 to 6 carbon atoms. The invention also relates to methods for preparing the said compounds and the composition comprising the same. The compounds of the present invention have the effect of β-receptor agonist and can be used for the treatment of asthma and bronchitis.
Career Highlights
Maosheng Cheng has worked at Shenyang Pharmaceutical University and Jinzhou Jiutai Pharmaceutical Co., Ltd. in China. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.
Collaborations
Maosheng Cheng has collaborated with notable coworkers such as Li Pan and Lie Ji. Their combined efforts have likely enhanced the innovation and research output in their respective fields.
Conclusion
Maosheng Cheng is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of respiratory conditions. His contributions to the field are noteworthy and reflect his dedication to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile